Skip to main content
Veterinary Medicines

FLUEQUIN T

Authorised
  • Influenza A virus, subtype H3N8, strain A/equine/Morava/95, Inactivated
  • Influenza A virus, subtype H7N7, strain A/equine/Prague/1956, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Brno/08, Inactivated
  • Clostridium tetani, toxoid

Product identification

Medicine name:
FLUEQUIN T
Active substance:
  • Influenza A virus, subtype H3N8, strain A/equine/Morava/95, Inactivated
  • Influenza A virus, subtype H7N7, strain A/equine/Prague/1956, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Brno/08, Inactivated
  • Clostridium tetani, toxoid
Target species:
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Influenza A virus, subtype H3N8, strain A/equine/Morava/95, Inactivated
    320.00
    haemagglutinating units
    /
    1.00
    millilitre(s)
  • Influenza A virus, subtype H7N7, strain A/equine/Prague/1956, Inactivated
    160.00
    haemagglutinating units
    /
    1.00
    millilitre(s)
  • Influenza A virus, subtype H3N8, strain A/equine/Brno/08, Inactivated
    320.00
    haemagglutinating units
    /
    1.00
    millilitre(s)
  • Clostridium tetani, toxoid
    150.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AL01
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120089
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 8/12/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."